Accuray (ARAY) Total Current Liabilities (2011 - 2026)
Accuray's (ARAY) quarterly Total Current Liabilities came in at $205.8 million in Q1 2026, up 40.42% year-on-year from $146.6 million in Q1 2025, and up 40.27% quarter-over-quarter from $146.8 million in Q4 2025.
Accuray (ARAY) Total Current Liabilities (2011 - 2026) Analysis & Trends
Accuray's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $205.8 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 40.42% year-over-year to $205.8 million in Q1 2026; TTM through Mar 2026 was $205.8 million, a 40.42% increase from a year earlier, with the FY2025 full-year figure at $192.6 million, up 71.37% from the prior year.
- Total Current Liabilities climbed to $205.8 million in Q1 2026 per ARAY's latest filing, from $146.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $205.8 million in Q1 2026 and bottomed at $57.9 million in Q2 2023.
- The 5-year median for Total Current Liabilities is $86.6 million (2023), against an average of $110.2 million.
- Across the five-year window, Total Current Liabilities soared 267.14% in 2022 and decreased 8.11% in 2023, its largest moves.
- Year by year, Total Current Liabilities stood at $75.0 million in 2022, then rose by 15.42% to $86.6 million in 2023, then jumped by 38.29% to $119.7 million in 2024, then advanced by 22.6% to $146.8 million in 2025, then soared by 40.27% to $205.8 million in 2026.
- Per Business Quant, the three latest ARAY Total Current Liabilities figures stand at $205.8 million (Q1 2026), $146.8 million (Q4 2025), and $194.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Accuray | 28,254.30 | -38.51 Mn | 25.29 Mn | 205.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205.84 Mn |
| Dec 31, 2025 | 146.75 Mn |
| Sep 30, 2025 | 194.61 Mn |
| Jun 30, 2025 | 192.58 Mn |
| Mar 31, 2025 | 146.59 Mn |
| Dec 31, 2024 | 119.70 Mn |
| Sep 30, 2024 | 118.75 Mn |
| Jun 30, 2024 | 112.38 Mn |
| Mar 31, 2024 | 79.30 Mn |
| Dec 31, 2023 | 86.55 Mn |
| Sep 30, 2023 | 76.34 Mn |
| Jun 30, 2023 | 57.90 Mn |
| Mar 31, 2023 | 70.19 Mn |
| Dec 31, 2022 | 74.99 Mn |
| Sep 30, 2022 | 66.62 Mn |
| Jun 30, 2022 | 63.01 Mn |
| Mar 31, 2022 | 61.88 Mn |
| Dec 31, 2021 | 52.09 Mn |
| Sep 30, 2021 | 53.70 Mn |
| Jun 30, 2021 | 24.45 Mn |